Exploring Trends in Anti-inflammatory Therapy
Safer, more potent steroids
are laying the groundwork
for new treatment strategies
for external ocular disease.
Practitioners share their experiences in a roundtable discussion.
 |
Paul M. Karpecki, O.D., F.A.A.O., Moderator
|
 |
Jimmy D. Bartlett, O.D., F.A.A.O. |
 |
Marc R. Bloomenstein, O.D., F.A.A.O. |
 |
Ron Melton, O.D., F.A.A.O. |
 |
Walter S. Ramsey, O.D., F.A.A.O. |
 |
Randall K. Thomas, O.D., M.P.H, F.A.A.O. |
Optometric Management, Issue: February 2005